{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-137894","form_type":"8-K","ticker":"IOBTQ","cik":"0001865494","company_name":"IO Biotech, Inc.","filed_at":"2025-06-09T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.244043+00:00","generated_at":"2026-05-19T17:32:47.469495+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"confidence":"high","headline":"IO Biotech stockholders elect David Smith to board, ratify EY as auditor","bullets":["David Smith elected as Class I director with 40,444,898 votes for, 3,010,542 withheld, 8,622,498 broker non-votes.","Ratification of EY Godkendt Revisionspartnerselskab as independent auditor: 51,581,966 for, 183,927 against, 312,045 abstain.","Annual Meeting held June 5, 2025; both proposals approved."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-137894","json":"https://secwatch.observer/filing/0001193125-25-137894.json","markdown":"https://secwatch.observer/filing/0001193125-25-137894.md","text":"https://secwatch.observer/filing/0001193125-25-137894.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1865494/000119312525137894/0001193125-25-137894-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1865494/000119312525137894/d908239d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T17:32:47.469495+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}